Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-05-24, Stock:JNJ, The news for the past five days is as follows:
2019-05-17: NEWS1: Trade war trades: 6 stocks.NEWS2: Why This Biotech Stock Looks Prime For A Johnson & Johnson Buyout.NEWS3: Exclusive: FBI targets Johnson & Johnson, Siemens, GE, Philips in Brazil graft case - Sources.NEWS4: Exclusive: FBI targets Johnson & Johnson, Siemens, GE, Philips in Brazil graft case - sources.NEWS5: Exclusive: FBI targets Johnson & Johnson, Siemens, GE, Philips in Brazil graft case - sources.NEWS6: U.S. FDA labels J&J surgical staplers' recall as severest.NEWS7: U.S. FDA labels J&J surgical staplers' recall as severest.NEWS8: Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs.NEWS9: Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs.NEWS10: Insiders Buy the Holdings of DLN ETF.NEWS11: Insiders Buy the Holdings of DLN ETF.NEWS12: FDA issues recall of J&J unit Ethicon's surgical staplers.NEWS13: Health Care Sector Update for 05/17/2019: ACHN, OTLK, MOR, JNJ, PFE, ABT, MRK, AMGN.NEWS14: Health Care Sector Update for 05/17/2019: ACHN, OTLK, MOR, JNJ, PFE, ABT, MRK, AMGN.NEWS15: Your first trade for Friday, May 17.NEWS16: Johnson & Johnson to Participate in Bernstein's 35th Annual Strategic Decisions Conference.NEWS17: Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs.
2019-05-20: NEWS1: Top Analyst Reports for Johnson & Johnson, Apple & Goldman Sachs.NEWS2: Top Analyst Reports for Johnson & Johnson, Apple & Goldman Sachs.NEWS3: ARWR: ARO-AAT Ph 2/3 Detailed, Could Serve as FDA Pivotal Study. Continued Broad-Based Pipeline Progress.NEWS4: Top Analyst Reports for Johnson & Johnson, Apple & Goldman Sachs.NEWS5: Drugmakers’ lobbying spending at 10-year high as Washington targets soaring prices.NEWS6: AbbVie's Brain Cancer Candidate Fails in Phase III Study.NEWS7: AbbVie's Brain Cancer Candidate Fails in Phase III Study.NEWS8: This is Why Johnson & Johnson (JNJ) is a Great Dividend Stock.NEWS9: This is Why Johnson & Johnson (JNJ) is a Great Dividend Stock.NEWS10: Health Care Sector Update for 05/20/2019: MDCO, QGEN, INNT, JNJ, PFE, ABT, MRK, AMGN.NEWS11: Health Care Sector Update for 05/20/2019: MDCO, QGEN, INNT, JNJ, PFE, ABT, MRK, AMGN.NEWS12: This is Why Johnson & Johnson (JNJ) is a Great Dividend Stock.NEWS13: AbbVie's Brain Cancer Candidate Fails in Phase III Study.NEWS14: After J&J sale, Cambridge investor sets sights on $175M raise for new medtech VC firm.
2019-05-21: NEWS1: West Chester company to eliminate 76 jobs.NEWS2: The Zacks Analyst Blog Highlights: Johnson & Johnson, Apple, Goldman Sachs, IBM and Netflix.NEWS3: The Zacks Analyst Blog Highlights: Johnson & Johnson, Apple, Goldman Sachs, IBM and Netflix.NEWS4: The Zacks Analyst Blog Highlights: Johnson & Johnson, Apple, Goldman Sachs, IBM and Netflix.NEWS5: 2 Stocks to be Wary Of (And One Defensive Play).
2019-05-22: NEWS1: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS2: Congo wants more use of Merck vaccine rather than J&J newcomer - minister.NEWS3: Ex-Dividend Reminder: Atmos Energy, Johnson & Johnson and Newmark Group.NEWS4: Ex-Dividend Reminder: Atmos Energy, Johnson & Johnson and Newmark Group.NEWS5: Health Care Sector Update for 05/22/2019: OBLN, CODX, AFMD, JNJ, PFE, ABT, MRK, AMGN.NEWS6: Health Care Sector Update for 05/22/2019: OBLN, CODX, AFMD, JNJ, PFE, ABT, MRK, AMGN.NEWS7: The Daily Biotech Pulse: Tocagen Tumbles, OncoSec Offering, Novartis Asthma Combo Drug Study.
2019-05-23: NEWS1: Health care recovery? 3 trades.NEWS2: The View from New Brunswick: Johnson & Johnson CEO Alex Gorsky at Healthy Returns.NEWS3: J&J's Invokana sNDA Gets Priority Review Status From FDA.NEWS4: J&J's Invokana sNDA Gets Priority Review Status From FDA.NEWS5: Better Buy: Johnson & Johnson vs. GlaxoSmithKline.NEWS6: Better Buy: Johnson & Johnson vs. GlaxoSmithKline.NEWS7: Health Care Sector Update for 05/23/2019: NVCN, IOVA, MDT, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Health Care Sector Update for 05/23/2019: NVCN, IOVA, MDT, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for May 24, 2019.NEWS10: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for May 24, 2019.NEWS11: Better Buy: Johnson & Johnson vs. GlaxoSmithKline.NEWS12: J&J's Invokana sNDA Gets Priority Review Status From FDA.NEWS13: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS14: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.

Answer: Decrease